Combining HRT and GLP-1: The Science Behind Better Weight Loss

You've done everything right—adjusted your diet, stayed active, tried every approach you can think of—and yet the weight keeps settling around your midsection in ways it never did before. If you're in perimenopause or menopause, your hormones may be working against you in ways that willpower alone can't fix.

Emerging research points to a promising combination: pairing hormone replacement therapy (HRT) with GLP-1 medications like semaglutide or tirzepatide. This article breaks down how these two treatments work together, what the science shows so far, and how to know if this approach might be right for you.

Why menopause and perimenopause make weight loss more challenging

Combining hormone replacement therapy (HRT) with glucagon-like peptide-1 (GLP-1) receptor agonists has become an increasingly common approach for treating menopausal weight gain, particularly stubborn visceral fat around the midsection. Emerging research suggests the combination may produce better weight loss outcomes than either treatment alone. HRT restores hormonal balance that affects metabolism, while GLP-1 medications reduce appetite and improve blood sugar regulation—two different pathways working toward the same goal.

If you're looking for convenient answers about whether HRT and GLP-1 can be used together, skip to What research shows. For a deeper understanding of why hormonal changes affect weight, start here.

Before exploring how HRT and GLP-1 work together, it helps to understand why hormonal shifts during perimenopause and menopause create unique weight challenges. Perimenopause refers to the transitional years before menopause, when hormone levels begin fluctuating. Menopause marks the point when menstrual periods stop permanently. During both phases, declining hormone levels fundamentally change how the body stores fat, burns energy, and responds to food. This is biology, not willpower.

How estrogen and progesterone affect metabolism

Estrogen plays a significant role in regulating where your body stores fat, how sensitive your cells are to insulin, and how your brain interprets hunger signals. When estrogen levels decline, the body shifts fat storage toward the midsection rather than the hips and thighs.

Progesterone also influences appetite regulation and fluid balance. As both hormones fluctuate and eventually decrease, the metabolic environment that once supported weight maintenance changes.

• Estrogen: Helps maintain insulin sensitivity and influences fat distribution
• Progesterone: Affects appetite signals and fluid retention
• The shift: As hormone levels decline, metabolic processes change in ways that can make weight loss harder

Why belly fat increases during hormonal transitions

You might notice weight settling differently during perimenopause and menopause—often around the midsection rather than the hips or thighs. Hormonal changes can make weight gain harder to control even when diet and exercise habits haven't changed.

Declining estrogen directs the body to store more visceral fat, which is fat that accumulates around internal organs. Visceral fat is metabolically active and associated with increased health risks, which is why addressing it matters beyond appearance.

The role of insulin resistance in midlife weight gain

Insulin resistance occurs when the body's cells become less responsive to insulin, making blood sugar management less efficient. Hormonal changes during menopause can worsen insulin resistance, creating a cycle that makes weight loss increasingly difficult.

This connection between hormones and insulin response is one reason why traditional diet and exercise approaches often feel less effective during this life stage.

How GLP-1 medications support weight loss during hormonal changes

GLP-1 medications work differently than traditional weight loss approaches. GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in the gut that regulates appetite and blood sugar. GLP-1 medications—including GLP-1 agonists like semaglutide and dual agonists like tirzepatide—work by targeting incretin pathways to reduce hunger, slow digestion, and improve blood sugar regulation.

Here's how GLP-1 medications affect the body:

• Appetite reduction: GLP-1s signal fullness to the brain, reducing overall food intake
• Blood sugar regulation: Helps manage insulin response, which is often disrupted during menopause
• Slower gastric emptying: Food moves through the stomach more slowly, extending feelings of satiety

For those wondering whether GLP-1s affect natural hormones like estrogen, the next section addresses that directly.

Does GLP-1 affect estrogen or other hormones

A common question is whether GLP-1 medications interact with or change natural hormone levels. The short answer: GLP-1 medications don't directly increase or replace estrogen, progesterone, or other reproductive hormones.

However, GLP-1s may indirectly support hormonal balance. Excess body fat can affect hormone production, so weight loss from GLP-1 medications may improve some hormonal imbalances related to carrying extra weight.

• Direct hormonal effects: GLP-1 medications don't replace or significantly alter estrogen or progesterone levels
• Indirect benefits: Weight loss from GLP-1s may improve hormonal imbalances related to excess body fat
• Key distinction: GLP-1s and HRT work through entirely different mechanisms, which is why combining them may offer complementary benefits

What research shows about using HRT and GLP-1 together

Emerging research suggests combining HRT with GLP-1 medications may produce better weight loss outcomes than either approach alone, with tirzepatide showing 20.9% weight reduction at 72 weeks in clinical studies. A Mayo Clinic study found postmenopausal women using hormone therapy alongside tirzepatide (a GLP-1/GIP dual agonist) experienced notably greater weight loss compared with those using tirzepatide without HRT.

The combination appears to work because HRT addresses the hormonal root cause of metabolic changes while GLP-1 targets appetite and blood sugar regulation. Results vary from person to person, and not everyone will experience the same outcomes.

Why HRT and GLP-1 may work better together

When used together, HRT and GLP-1 address weight gain from multiple angles. Each treatment targets different aspects of the problem, which may explain why some people experience better results with both.

HRT restores hormonal balance that affects metabolism

HRT—particularly estrogen, sometimes with progesterone—helps restore the hormonal environment that supports healthy metabolism, fat distribution, and insulin sensitivity. Transdermal estrogen (applied through the skin) and micronized progesterone are often considered when combining with other medications. HRT addresses the metabolic slowdown at its hormonal source rather than just managing symptoms.

GLP-1 targets appetite and blood sugar regulation

While HRT addresses the hormonal environment, GLP-1 directly reduces appetite, improves satiety signals, and helps with insulin response. The two treatments work through different pathways toward the same goal of sustainable weight loss.

Combined benefits for visceral fat and body composition

Together, HRT and GLP-1 may more effectively target stubborn visceral fat that accumulates during menopause. HRT may also help preserve lean muscle mass during weight loss—important because calorie reduction can sometimes lead to muscle loss alongside fat loss.

Can GLP-1 medications help with hot flashes and other menopause symptoms

While GLP-1 medications are primarily prescribed for weight management, some people wonder whether they affect other menopause symptoms. GLP-1s are not approved or primarily intended to treat hot flashes, sleep disruption, or other vasomotor symptoms—that's what HRT addresses.

That said, weight loss and improved metabolic health may indirectly ease some symptoms for some people. The key is understanding what each treatment is designed to do and setting realistic expectations.

How to manage side effects when using GLP-1 during menopause

Both HRT and GLP-1 can have side effects, and using them together requires attention to how your body responds.

Common gastrointestinal symptoms and how to ease them

GLP-1 medications commonly cause gastrointestinal side effects, especially when starting treatment:

• Nausea: Often improves with time; eating smaller meals and avoiding fatty foods may help
• Constipation: Staying hydrated and eating fiber-rich foods can provide relief
• Reduced appetite: Working with a clinician to ensure adequate nutrition is important

The adjustment period and what to expect

Side effects are often most noticeable when starting medication or increasing doses. Gradual dose titration—sometimes called "start low, go slow"—helps minimize discomfort. Fatigue or energy changes may also occur as the body adjusts.

When to talk to your clinician about your treatment plan

Ongoing communication with a clinician is especially important when using multiple treatments. Signs that warrant a conversation include persistent side effects, concerns about interactions, or results that aren't meeting expectations.

How to preserve muscle while losing weight on GLP-1

One concern with any significant weight loss is losing muscle00272-9/abstract) along with fat. Muscle mass affects metabolism, strength, and long-term weight maintenance, so protecting lean mass matters.

Why protein intake matters more during weight loss

Adequate protein helps preserve muscle during calorie restriction. Prioritizing protein at meals becomes especially important when appetite is reduced on GLP-1 medications—some people find eating enough protein challenging when they're simply not as hungry.

The role of resistance training in maintaining lean mass

Strength training signals the body to maintain muscle even during weight loss. HRT may also support better response to strength training for some people, creating another potential benefit of the combination approach.

Tracking progress beyond the scale

Looking at body composition changes, energy levels, how clothes fit, and overall strength can provide a more complete picture than weight alone. Sustainable weight care focuses on long-term health rather than just numbers.

Who may benefit from combined HRT and GLP-1 treatment

Not everyone wants or benefits from both treatments, but certain situations may make the combination worth exploring with a clinician:

• People in perimenopause or menopause experiencing stubborn weight changes despite consistent efforts
• Those already on HRT who want additional support for weight management
• People experiencing weight changes alongside metabolic concerns to discuss with a clinician
• Those who haven't responded well to GLP-1 alone and have hormonal factors at play

What works for one person may not be appropriate for another. Individual assessment is essential.

Important considerations when combining HRT and GLP-1

Before starting or combining HRT and GLP-1, there are several factors to discuss with a clinician:

• Not all HRT formulations are the same: Transdermal estrogen and micronized progesterone are often preferred when combining with other medications
• Individual risk factors matter: History of certain cancers, cardiovascular issues, or blood clots affects HRT suitability
• Monitoring is important: Regular check-ins help ensure both treatments are working well together
• Timing and dosing: A clinician can help determine whether to start treatments simultaneously or sequentially

A personalized approach to weight loss during hormonal changes

Because every body responds differently to hormonal shifts and medications, personalized care makes a meaningful difference in outcomes. The right combination of treatments, lifestyle guidance, and ongoing support varies from person to person.

Working with clinicians who understand both weight care and hormonal health can help identify the most appropriate treatment path. Found's approach includes MetabolicPrint™—its proprietary metabolic health assessment engine—plus access to a wide range of prescription medications, including GLP-1 medications, with ongoing clinician support.

Found is among the largest medically-supported telehealth weight care platforms in the country, having served more than 250,000 members to date. To discover your MetabolicPrint and start your journey with Found, take our quiz. *Individual results may vary.

Prescriptions are provided only if clinically appropriate after evaluation by a licensed provider.

Individual results may vary.

FAQs about HRT and GLP-1 for weight loss

Can you take GLP-1 medications if you're on birth control?

GLP-1 medications may affect how quickly oral medications are absorbed, so discussing timing with a clinician is important. In some cases, non-oral contraceptive methods may be recommended.

How long does it typically take to see weight loss results when combining HRT and GLP-1?

Timelines vary significantly from person to person based on individual factors, dosing, and lifestyle. Many people begin noticing changes within the first few months, though sustainable results develop over time.

What happens to weight if you stop taking GLP-1 but continue HRT?

Weight regain is possible when stopping GLP-1 medications, as the appetite-suppressing effects diminish. Continuing HRT and maintaining lifestyle habits may help, but ongoing weight management is important to discuss with a clinician.

Are there any medications that shouldn't be combined with GLP-1s and HRT?

Certain medications may interact with GLP-1s or HRT, so providing a complete medication list to your clinician is essential. A clinician can identify potential interactions and adjust your treatment plan accordingly.